Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC.TMCI · Entity 5943 | SVP, Sales | August 09, 2025 | August 13, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
TREACE MEDICAL CONCEPTS, INC.
Report date August 09, 2025 · Filed August 13, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 205,092 |
Reported balance
After 2025-08-09 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-08-09 · Tax withholding · Disposed 4,907 · Balance 205,092 F1: Includes 181,955 restricted stock units. |
Filing footnotes · ownership attribution and instrument terms
F1: Includes 181,955 restricted stock units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 09, 2025 Filed Aug 13, 2025 01:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 4,907 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-107554 · ownership.xml · nonDerivative · entry 1 Berutti Aaron · CIK 0001871334 · SVP, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,092 F1 · balance_after: Includes 181,955 restricted stock units. Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 01:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 1,815 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-037575 · ownership.xml · nonDerivative · entry 2 Berutti Aaron · CIK 0001871334 · SVP, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 209,999 F2 · balance_after: Includes 202,105 restricted stock units Read SEC document |
| March 08, 2025 Filed Mar 12, 2025 01:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 728 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-037575 · ownership.xml · nonDerivative · entry 1 Berutti Aaron · CIK 0001871334 · SVP, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 211,814 F1 · balance_after: Includes 209,555 restricted stock units Read SEC document |
| January 22, 2025 Filed Jan 25, 2025 02:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-008974 · ownership.xml · nonDerivative · entry 1 Berutti Aaron · CIK 0001871334 · SVP, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 212,542 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 22, 2026 and the last installment vesting on January 22, 2029; subject to Reporting Person's providing continued service to Issuer through each vesting date. F2 · balance_after: Includes 212,542 restricted stock units. Read SEC document |
| January 10, 2025 Filed Jan 15, 2025 02:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 4,821 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-005578 · ownership.xml · nonDerivative · entry 1 Berutti Aaron · CIK 0001871334 · SVP, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 160,970 F1 · balance_after: Includes 145,454 restricted stock units Read SEC document |
| August 09, 2024 Filed Aug 10, 2024 01:30 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 60,450 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-095010 · ownership.xml · nonDerivative · entry 1 Berutti Aaron · CIK 0001871334 · SVP, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 165,791 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in three equal annual installments on the first, second and third anniversaries of the grant date; subject to Reporting Person's providing continued service to Issuer through each vesting date. F2 · balance_after: Includes 161,711 restricted stock units Read SEC document |
| March 10, 2024 Filed Mar 13, 2024 01:55 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 1,815 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-030473 · ownership.xml · nonDerivative · entry 2 Berutti Aaron · CIK 0001871334 · SVP, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,341 F2 · balance_after: Includes 101,261 restricted stock units Read SEC document |
| March 08, 2024 Filed Mar 13, 2024 01:55 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | Tax withholdingCommon Stock | 711 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-030473 · ownership.xml · nonDerivative · entry 1 Berutti Aaron · CIK 0001871334 · SVP, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,156 F1 · balance_after: Includes 103,076 restricted stock units Read SEC document |
| January 10, 2024 Filed Jan 13, 2024 02:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option (Right to Buy) · Derivative | 73,200 | $0.00 Strike: $13.46 | $0.00 |
DisclosureSEC source: 0001209191-24-001593 · doc4.xml · derivative · entry 2 Berutti Aaron · CIK 0001871334 · Sr. VP, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 73,200 Underlying: Stock Option (Right to Buy) · 73,200 shares Expires 2034-01-10 F3 · derivative.exercise_date: The stock option vests in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and the last installment vesting on January 10, 2028, subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| January 10, 2024 Filed Jan 13, 2024 02:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 65,025 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001593 · doc4.xml · nonDerivative · entry 1 Berutti Aaron · CIK 0001871334 · Sr. VP, Sales 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,867 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, with the first installment vesting on January 10, 2025 and with the last installment vesting on January 10, 2028; subject to Reporting Person's providing continued service to Issuer through each vesting date. F2 · balance_after: Includes 103,787 RSUs. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option (Right to Buy) · Derivative | 67,500 | $0.00 Strike: $24.07 | $0.00 |
DisclosureSEC source: 0001209191-23-018044 · doc4.xml · derivative · entry 3 Berutti Aaron · CIK 0001871334 · Sr. VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,500 Underlying: Stock Option (Right to Buy) · 67,500 shares Expires 2033-03-10 F5 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| March 10, 2023 Filed Mar 11, 2023 02:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 29,800 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-018044 · doc4.xml · nonDerivative · entry 2 Berutti Aaron · CIK 0001871334 · Sr. VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,842 F3 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 10, 2024 with the last installment on March 10, 2027; subject to Reporting Person's providing continued service to Issuer through each vesting date. F4 · balance_after: Includes 38,762 RSUs. Read SEC document |
| March 09, 2023 Filed Mar 11, 2023 02:00 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | SaleCommon Stock | 733 | $24.41 | $17,892.53 |
DisclosureSEC source: 0001209191-23-018044 · doc4.xml · nonDerivative · entry 1 Berutti Aaron · CIK 0001871334 · Sr. VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,042 F1 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F1 · shares: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. F2 · balance_after: Includes 8,962 RSUs. Read SEC document |
| November 21, 2022 Filed Nov 21, 2022 23:32 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | PurchaseCommon Stock | 1,825 | $21.86 | $39,894.32 |
DisclosureSEC source: 0001209191-22-058268 · doc4.xml · nonDerivative · entry 1 Berutti Aaron · CIK 0001871334 · Sr. VP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,775 F1 · balance_after: Includes 11,950 RSUs. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 01:21 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option (Right to Buy) · Derivative | 92,100 | $0.00 Strike: $19.15 | $0.00 |
DisclosureSEC source: 0001567619-22-006726 · doc1.xml · derivative · entry 2 Berutti Aaron · CIK 0001871334 · SVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 92,100 Underlying: Common Stock · 92,100 shares Expires 2032-03-08 F3 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
| March 08, 2022 Filed Mar 11, 2022 01:21 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantCommon Stock | 11,950 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-22-006726 · doc1.xml · nonDerivative · entry 1 Berutti Aaron · CIK 0001871334 · SVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,950 F1 · shares: Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on March 8, 2023 with the last installment on March 8, 2026? subject to Reporting Person's providing continued service to Issuer through each vesting date. F2 · balance_after: Includes 11,950 RSUs. Read SEC document |
| August 03, 2021 Filed Aug 5, 2021 23:20 UTC | TREACE MEDICAL CONCEPTS, INC. TMCI · Entity 5943 | GrantStock Option (Right to Buy) · Derivative | 150,000 | $0.00 Strike: $29.26 | $0.00 |
DisclosureSEC source: 0001567619-21-014559 · doc1.xml · derivative · entry 1 Berutti Aaron · CIK 0001871334 · SVP, Sales 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 150,000 Underlying: Common Stock · 150,000 shares Expires 2021-08-03 F1 · derivative.exercise_date: The stock option will vest in equal annual installments over 4 years, commencing on August 3, 2022, with the last installment on August 3, 2025 subject to Reporting Person's providing continued service to Issuer through each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.